Improvement in Signs and Symptoms of Active Ankylosing Spondylitis Following Treatment with Anti-Interleukin (IL)-17A Monoclonal Antibody Secukinumab Are Paralleled by Reductions i... by Baeten, D, Bek, S, Wei, J, Brachat, A, Sieper, J, Emery, P, Braun, J, van der Heijde, D, McInnes, I, van Laar, J, Landewe, R, Wordsworth, P, Wollenhaupt, J, Kellner, H, Paramarta, J, Bertolino, A, Wright, A, Wolfgang, H

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. by Baeten, D, Baraliakos, X, Braun, J, Sieper, J, Emery, P, van der Heijde, D, McInnes, I, van Laar, J, Landewé, R, Wordsworth, P, Wollenhaupt, J, Kellner, H, Paramarta, J, Wei, J, Brachat, A, Bek, S, Laurent, D, Li, Y, Wang, Y, Bertolino, A, Gsteiger, S, Wright, A, Hueber, W